American Association for Cancer Research

The Future of Cancer Research: Science and Patient Impact

AACR Roswell Park Cancer Institute

Docking study of a celecoxib derivative against PKA. Credit: Y. H. Tan, K. H. Lee, T. Lin, Y. C. Sun, H. M. Hsieh-Li, H. F. Juan,Y.C.Wang, Clin Cancer Res 2008 14: 1823-1830.



October 27 - 28, 2008
Roswell Park Cancer Institute
Buffalo, New York

VIEW PROGRAM


DOWNLOAD BROCHURE*
*(Adobe Acrobat Reader required)



The AACR Centennial Symposium: The Future of Cancer Research: Science and Patient Impact focused on the latest and future advances in cancer research, technologies, and techniques. This forward-looking centennial symposium honored the long history that the AACR has had with the Roswell Park Cancer Institute. This symposium was a Continuing Medical Education (CME) activity, AMA PRA Category 1 Credits were available.

CHAIRPERSONS:
Raymond N. DuBois, UT M. D. Anderson Cancer Center, Houston, TX
Donald L. Trump, Roswell Park Cancer Institute, Buffalo, NY

SCIENTIFIC PROGRAM COMMITTEE:
Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, NY
Clara D. Bloomfield, Ohio State University Comprehensive Cancer Center, Columbus, OH
William S. Dalton, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Roy S. Herbst, UT M.D. Anderson Cancer Center, Houston, TX
Candace S. Johnson, Roswell Park Cancer Institute, Buffalo, NY
Kelvin P. Lee, Roswell Park Cancer Institute, Buffalo, NY
Edwin A. Mirand, Roswell Park Cancer Institute, Buffalo, NY
William G. Nelson, V, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Frank J. Rauscher, III, The Wistar Institute, Philadelphia, PA
Youcef M. Rustum, Roswell Park Cancer Institute, Buffalo, NY